Sifei Xing

1.9k total citations
9 papers, 1.1k citations indexed

About

Sifei Xing is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Sifei Xing has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Virology, 7 papers in Infectious Diseases and 4 papers in Immunology. Recurrent topics in Sifei Xing's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (7 papers) and Immune Cell Function and Interaction (4 papers). Sifei Xing is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (7 papers) and Immune Cell Function and Interaction (4 papers). Sifei Xing collaborates with scholars based in United States, Taiwan and China. Sifei Xing's co-authors include Robert F. Siliciano, Liang Shan, Hung‐Chih Yang, Jun O. Liu, Joseph B. Margolick, Shridhar Bhat, Hao Zhang, Lin Shen, Janet D. Siliciano and Yefei Han and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Immunity.

In The Last Decade

Sifei Xing

9 papers receiving 1.1k citations

Peers

Sifei Xing
Fiona Wightman Australia
Amy M. Princiotto United States
Malcolm Macartney United Kingdom
Serena Xu United States
Alyssa R. Martin United States
Amanda M. Crooks United States
Gabriela Turk Argentina
Fiona Wightman Australia
Sifei Xing
Citations per year, relative to Sifei Xing Sifei Xing (= 1×) peers Fiona Wightman

Countries citing papers authored by Sifei Xing

Since Specialization
Citations

This map shows the geographic impact of Sifei Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sifei Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sifei Xing more than expected).

Fields of papers citing papers by Sifei Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sifei Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sifei Xing. The network helps show where Sifei Xing may publish in the future.

Co-authorship network of co-authors of Sifei Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Sifei Xing. A scholar is included among the top collaborators of Sifei Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sifei Xing. Sifei Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Shan, Liang, Kai Deng, Hongbo Gao, et al.. (2017). Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection. Immunity. 47(4). 766–775.e3. 132 indexed citations
2.
Shan, Liang, Sifei Xing, Hung‐Chih Yang, et al.. (2013). Unique characteristics of histone deacetylase inhibitors in reactivation of latent HIV-1 in Bcl-2-transduced primary resting CD4+ T cells. Journal of Antimicrobial Chemotherapy. 69(1). 28–33. 26 indexed citations
3.
Boehm, Daniela, Vincenzo Calvanese, Roy D. Dar, et al.. (2013). BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. Cell Cycle. 12(3). 452–462. 184 indexed citations
4.
Xing, Sifei & Robert F. Siliciano. (2012). Targeting HIV latency: pharmacologic strategies toward eradication. Drug Discovery Today. 18(11-12). 541–551. 126 indexed citations
5.
Xing, Sifei, Shridhar Bhat, Hao Zhang, et al.. (2011). Novel structurally related compounds reactivate latent HIV-1 in a bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation. Journal of Antimicrobial Chemotherapy. 67(2). 398–403. 36 indexed citations
6.
Xing, Sifei, C. Korin Bullen, Liang Shan, et al.. (2011). Disulfiram Reactivates Latent HIV-1 in a Bcl-2-Transduced Primary CD4 + T Cell Model without Inducing Global T Cell Activation. Journal of Virology. 85(12). 6060–6064. 162 indexed citations
7.
Shen, Lin, S. Alireza Rabi, Ahmad R. Sedaghat, et al.. (2011). A Critical Subset Model Provides a Conceptual Basis for the High Antiviral Activity of Major HIV Drugs. Science Translational Medicine. 3(91). 91ra63–91ra63. 55 indexed citations
8.
Yang, Hung‐Chih, Sifei Xing, Liang Shan, et al.. (2009). Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. Journal of Clinical Investigation. 119(11). 3473–86. 219 indexed citations
9.
McMahon, Moira A., Benjamin L. Jilek, Timothy Brennan, et al.. (2007). The HBV Drug Entecavir — Effects on HIV-1 Replication and Resistance. New England Journal of Medicine. 356(25). 2614–2621. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026